Patrik Jeanmonod sold $50k of CTKB
Chief Financial Officer at Cytek Biosciences, Inc.. 3,500 shares at an average of $14.30, traded Nov 25, 2022, filed Nov 28, 2022.
Score components
- +22RoleCFO
- +7Trade size$50k at market
- 0Share of holdings soldSold 4.0% of holdings
- +15Cluster4 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001209191-22-058890, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 25, 2022 | SOpen-market sale Common Stock10b5-1 | -3,500 | $14.30 | $50k | 83,132 | Nov 28, 2022 |
Related signals
Other insiders at Cytek Biosciences, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 42Moderate | CTKBbuy Cytek Biosciences, Inc. | William D. McCombe Chief Financial Officer | $97k 35,000 shares | +169% | |
| 5Weak | Cytek Biosciences, Inc. | Ming Yan CHIEF TECHNOLOGY OFFICER | $117k 20,000 shares | -0% | |
| 0Weak | Cytek Biosciences, Inc. | Ming Yan CHIEF TECHNOLOGY OFFICER | $13k 1,900 shares | -0% | |
| 8Weak | Cytek Biosciences, Inc. | Ming Yan CHIEF TECHNOLOGY OFFICER | $270k 40,000 shares | -1% | |
| 15Weak | Cytek Biosciences, Inc. | Patrik Jeanmonod Chief Financial Officer | $29k 3,000 shares | -3% | |
| 15Weak | Cytek Biosciences, Inc. | Ming Yan Chief Technology Officer | $189k 20,000 shares | -0% | |
| 10Weak | Cytek Biosciences, Inc. | Patrik Jeanmonod Chief Financial Officer | $21k 3,000 shares | -3% | |
| 5Weak | Cytek Biosciences, Inc. | Ming Yan Chief Technology Officer | $121k 20,000 shares | -0% | |
| 29Weak | Cytek Biosciences, Inc. | Wenbin Jiang President and CEO | $87k 20,000 shares | -0% | |
| 17Weak | Cytek Biosciences, Inc. | Patrik Jeanmonod Chief Financial Officer | $14k 3,000 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.